Literature DB >> 33694024

Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey.

Koh-Hei Sonoda1, Eiichi Hasegawa2, Kenichi Namba3, Annabelle A Okada4, Nobuyuki Ohguro5, Hiroshi Goto6.   

Abstract

PURPOSE: To investigate the epidemiology of uveitis in Japan and assess its changes over time. STUDY
DESIGN: Retrospective multicenter study
METHODS: Sixty-six hospitals in Japan with uveitis specialty clinics participated in this retrospective nationwide survey. A questionnaire was sent to each hospital to survey the total number of patients who made a first visit to the outpatient uveitis clinic of each hospital between 1 April 2016 and 31 March 2017. The diagnosis of uveitis was based on guidelines when available or on commonly used diagnostic criteria.
RESULTS: In 2016, new patients with uveitis accounted for 3.2% of the total number of new patients with ophthalmic diseases. A total of 5378 patients were enrolled in the survey; 3408 cases could be classified with a specific uveitis entity, and 1970 cases were described as unclassified intraocular inflammation. Among the classified cases, the most frequent disease was sarcoidosis (10.6%), followed by Vogt-Koyanagi-Harada disease (8.1%), herpetic iritis (6.5%), acute anterior uveitis (5.5%), sclerouveitis (4.4%), Behçet's disease (4.2%), malignant disease (2.6%), acute retinal necrosis (1.7%), Posner-Schlossman syndrome (1.7%), and diabetic iritis (1.4%). The rates of sarcoidosis, Vogt-Koyanagi-Harada disease, and Behçet's disease were similar; however, the rate of herpes iritis increased (4.2-6.5%) when compared with the 2009 survey.
CONCLUSIONS: Some changes were observed between the previous nationwide surveys (2002 and 2009) and the present survey. It must be valuable to continue such nationwide epidemiologic surveys at regular intervals.

Entities:  

Keywords:  Epidemiology; Intraocular inflammation; Survey; Uveitis

Year:  2021        PMID: 33694024     DOI: 10.1007/s10384-020-00809-1

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  2 in total

1.  [Validity, usefulness and difficulties of the diagnosis of sarcoidosis by new diagnostic criteria and guidelines for sarcoidosis].

Authors:  Mami Ishihara
Journal:  Nippon Ganka Gakkai Zasshi       Date:  2010-08

2.  Classification of childhood arthritis: divide and conquer.

Authors:  R E Petty; T R Southwood
Journal:  J Rheumatol       Date:  1998-10       Impact factor: 4.666

  2 in total
  11 in total

1.  Mucosal-associated invariant T cells have therapeutic potential against ocular autoimmunity.

Authors:  Satoshi Yamana; Kensuke Shibata; Eiichi Hasegawa; Mitsuru Arima; Shotaro Shimokawa; Nobuyo Yawata; Atsunobu Takeda; Sho Yamasaki; Koh-Hei Sonoda
Journal:  Mucosal Immunol       Date:  2021-11-13       Impact factor: 7.313

2.  Clinical features and visual outcomes of ocular sarcoidosis at a tertiary referral center in Tokyo.

Authors:  Katsuya Nagahori; Hiroshi Keino; Makiko Nakayama; Takayo Watanabe; Yoshimasa Ando; Isami Hayashi; Shinya Abe; Annabelle A Okada
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-05-26       Impact factor: 3.535

3.  Human U90926 orthologous long non-coding RNA as a novel biomarker for visual prognosis in herpes simplex virus type-1 induced acute retinal necrosis.

Authors:  Shintaro Shirahama; Kenzui Taniue; Shuhei Mitsutomi; Rie Tanaka; Toshikatsu Kaburaki; Tomohito Sato; Masaru Takeuchi; Hidetoshi Kawashima; Yoshihiro Urade; Makoto Aihara; Nobuyoshi Akimitsu
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

4.  Clinical Characteristics and Efficacy of Adalimumab and Low-Dose Methotrexate Combination Therapy in Patients With Vogt-Koyanagi-Harada Disease.

Authors:  Tomona Hiyama; Yosuke Harada; Yoshiaki Kiuchi
Journal:  Front Med (Lausanne)       Date:  2022-01-06

Review 5.  TNF-α in Uveitis: From Bench to Clinic.

Authors:  Qi Jiang; Zhaohuai Li; Tianyu Tao; Runping Duan; Xianggui Wang; Wenru Su
Journal:  Front Pharmacol       Date:  2021-11-02       Impact factor: 5.810

6.  Long-Term Safety and Effectiveness of Adalimumab in Japanese Patients with Noninfectious Intermediate, Posterior, or Panuveitis: Post-Marketing Surveillance of 251 Patients.

Authors:  Kenichi Namba; Toshikatsu Kaburaki; Hidekazu Tsuruga; Yohei Ogawa; Eri Iwashita; Hiroshi Goto
Journal:  Ophthalmol Ther       Date:  2022-03-19

Review 7.  Updates on HTLV-1 Uveitis.

Authors:  Koju Kamoi; Toshiki Watanabe; Kaoru Uchimaru; Akihiko Okayama; Seiko Kato; Toyotaka Kawamata; Hisako Kurozumi-Karube; Noe Horiguchi; Yuan Zong; Yoshihisa Yamano; Isao Hamaguchi; Yasuhito Nannya; Arinobu Tojo; Kyoko Ohno-Matsui
Journal:  Viruses       Date:  2022-04-12       Impact factor: 5.818

8.  Comprehensive Proteomic Profiling of Vitreous Humor in Ocular Sarcoidosis Compared with Other Vitreoretinal Diseases.

Authors:  Hiroyuki Komatsu; Yoshihiko Usui; Kinya Tsubota; Risa Fujii; Takefumi Yamaguchi; Kazuichi Maruyama; Ryo Wakita; Masaki Asakage; Hiroyuki Shimizu; Naoyuki Yamakawa; Naoya Nezu; Koji Ueda; Hiroshi Goto
Journal:  J Clin Med       Date:  2022-06-22       Impact factor: 4.964

9.  Molecular Signatures of Natural Killer Cells in CMV-Associated Anterior Uveitis, A New Type of CMV-Induced Disease in Immunocompetent Individuals.

Authors:  Nobuyo Yawata; Mariko Shirane; Kaing Woon; Xinru Lim; Hidenori Tanaka; Yoh-Ichi Kawano; Makoto Yawata; Soon-Phaik Chee; Jay Siak; Koh-Hei Sonoda
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923

10.  Long-term incidence of posterior capsular opacification in patients with non-infectious uveitis.

Authors:  Yuki Kitaguchi-Iwakiri; Koju Kamoi; Hiroshi Takase; Yusuke Okubo; Kyoko Ohno-Matsui
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.